Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stem Cell RC is a Lithuania-based contract development and manufacturing organization (CDMO) and contract research organization (CRO) specializing in stem cell and cell therapeutics. As part of the Northway group, the company provides a range of services including research, preclinical studies, and GMP-compliant manufacturing of cell-based products. It operates within the Stem Cell and Regenerative Cluster in Vilnius, collaborating with hospitals and R&D institutions to advance regenerative medicine. The company's facilities include state-of-the-art R&D laboratories and cGMP manufacturing suites designed for the development and production of advanced therapy medicinal products (ATMPs). Stem Cell RC serves as the manager of the Lithuanian Stem Cell and Regenerative Cluster, facilitating innovation and commercialization in the field of cell therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Cell RC.